Novo Unveils Oral Wegovy in the US, With Out-of-Pocket Prices at $149 Per Month

After getting the crucial first-mover advantage with an FDA approval for a weight loss pill, Novo looks to win the market before rival Lilly can arrive with its own oral option for obesity.